Shaping the Future of Respiratory Care: The ERS Alpha-1 Antitrypsin Conference 2026 on July 21, 2026 Posted by
The Spicy Paradox: Unpacking the Complex Relationship Between Chili Peppers and Cancer Risk on July 21, 2026 Posted by
Advancing the Frontier of Bipolar Disorder Treatment: From Magnetic Seizures to Metabolic Interventions on July 21, 2026 Posted by
Beyond Willpower: Why Your Body Changes After 50 and How to Reclaim Your Shape on July 21, 2026 Posted by
Medtronic Unveils Real-Time AI Platform: A New Era for Robotic-Assisted Surgery on July 21, 2026 Posted by
The "Black Box" Controversy: Data, Deception, and the Two-Decade Debate Over Youth Antidepressants on July 21, 2026 Posted by
Retinal Nerve Fiber Thickening Linked to Geographic Atrophy Treatments: A Clinical Conundrum on July 21, 2026 Posted by
Shaping the Future of Respiratory Care: The ERS Alpha-1 Antitrypsin Conference 2026 on July 21, 2026 Posted by
The Spicy Paradox: Unpacking the Complex Relationship Between Chili Peppers and Cancer Risk on July 21, 2026 Posted by
Advancing the Frontier of Bipolar Disorder Treatment: From Magnetic Seizures to Metabolic Interventions on July 21, 2026 Posted by
Beyond Willpower: Why Your Body Changes After 50 and How to Reclaim Your Shape on July 21, 2026 Posted by
Posted in Medical Innovations Eli Lilly Doubles Down on Non-Opioid Innovation with 4E Therapeutics Acquisition on June 16, 2026
Posted in Medical Innovations Eli Lilly’s New Myelofibrosis Candidate Challenges Incyte’s Market Dominance Following Strong Phase 1 Data on June 16, 2026
Posted in Digital Health Tools Abridge Accelerates AI Integration: Strategic Alliances with Nvidia and Eli Lilly Signal New Era in Clinical Intelligence on June 14, 2026
Posted in Digital Health Tools Biotech Markets in Flux: Legend Biotech’s Surge, Lilly’s Expansion, and the Shifting Regulatory Landscape on June 4, 2026 rifanmuazin
Posted in Medical Innovations Eli Lilly Doubles Down on Genetic Medicine: A $1.9 Billion Bet on Ascidian’s RNA Exon Editing on June 3, 2026 rifanmuazin
Posted in Digital Health Tools The 340B Stand-Off: Eli Lilly Escalates Data Dispute with Hospitals on June 3, 2026 rifanmuazin
Posted in Medical Innovations The High-Stakes Showdown: Eli Lilly Escalates Battle Over 340B Drug Discount Program on June 2, 2026 rifanmuazin
Posted in Digital Health Tools Escalating Standoff: Eli Lilly Issues Ultimatum to Hospitals Over 340B Drug Pricing on June 2, 2026 rifanmuazin
Posted in Medical Innovations The Great Weight-Loss War: CVS Shifts Strategy to Level the Playing Field for Lilly and Novo Nordisk on May 31, 2026 rifanmuazin
Posted in Digital Health Tools The Triple-Agonist Frontier: Eli Lilly’s Retatrutide Sets a New Benchmark in Obesity Treatment on May 22, 2026 rifanmuazin
